These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3109868)

  • 1. [Non-steroidal anti-inflammatory agents increase intestinal permeability].
    Auer IO; Habscheid W; Hiller S; Gerhards W; Eilles C
    Dtsch Med Wochenschr; 1987 Jun; 112(26):1032-7. PubMed ID: 3109868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs.
    Mielants H; Goemaere S; De Vos M; Schelstraete K; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):389-93. PubMed ID: 1906938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability].
    Busch J; Hammer M; Brunkhorst R; Wagener P
    Z Rheumatol; 1988; 47(3):156-60. PubMed ID: 3213262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal permeability in patients with Crohn's disease and their first-degree relatives.
    Howden CW; Gillanders I; Morris AJ; Duncan A; Danesh B; Russell RI
    Am J Gastroenterol; 1994 Aug; 89(8):1175-6. PubMed ID: 8053430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of intestinal permeability using 51Cr-EDTA.
    Peled Y; Watz C; Gilat T
    Am J Gastroenterol; 1985 Oct; 80(10):770-3. PubMed ID: 3929593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different measurements of intestinal permeability in inflammatory bowel disease.
    Howden CW; Robertson C; Duncan A; Morris AJ; Russell RI
    Am J Gastroenterol; 1991 Oct; 86(10):1445-9. PubMed ID: 1928036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.
    Mielants H; De Vos M; Goemaere S; Schelstraete K; Cuvelier C; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):394-400. PubMed ID: 1906939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal permeability compared in pediatric and adult patients with inflammatory bowel disease.
    Issenman RM; Jenkins RT; Radoja C
    Clin Invest Med; 1993 Jun; 16(3):187-96. PubMed ID: 8365046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.
    Jenkins RT; Jones DB; Goodacre RL; Collins SM; Coates G; Hunt RH; Bienenstock J
    Am J Gastroenterol; 1987 Nov; 82(11):1159-64. PubMed ID: 3118697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do non-steroidal anti-inflammatory drugs increase colonic permeability?
    Jenkins AP; Trew DR; Crump BJ; Nukajam WS; Foley JA; Menzies IS; Creamer B
    Gut; 1991 Jan; 32(1):66-9. PubMed ID: 1899408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the 51Cr-EDTA urinary recovery test for assessment of intestinal permeability in the horse.
    Escala J; Gatherer ME; Voûte L; Love S
    Res Vet Sci; 2006 Apr; 80(2):181-5. PubMed ID: 16143355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man.
    Oman H; Blomquist L; Henriksson AE; Johansson SG
    Scand J Gastroenterol; 1995 Dec; 30(12):1172-7. PubMed ID: 9053970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.
    Bjarnason I; Williams P; So A; Zanelli GD; Levi AJ; Gumpel JM; Peters TJ; Ansell B
    Lancet; 1984 Nov; 2(8413):1171-4. PubMed ID: 6150232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between lactulose-mannitol test and 51Cr-labelled ethylene diamine tetra-acetate test in inflammatory bowel diseases.
    Andre C; Descos L; Minaire Y
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():113-7. PubMed ID: 2128072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is an increased intestinal permeability a valid predictor of relapse in Crohn disease?
    Jørgensen J; Ranløv PJ; Bjerrum PJ; Diemer H; Bisgaard K; Elsborg L
    Scand J Gastroenterol; 2001 May; 36(5):521-7. PubMed ID: 11346207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased intestinal permeability in active pulmonary sarcoidosis.
    Wallaert B; Colombel JF; Adenis A; Marchandise X; Hallgren R; Janin A; Tonnel AB
    Am Rev Respir Dis; 1992 Jun; 145(6):1440-5. PubMed ID: 1596016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of canine intestinal permeability, using 51Cr-labeled ethylenediaminetetraacetate.
    Hall EJ; Batt RM; Brown A
    Am J Vet Res; 1989 Dec; 50(12):2069-74. PubMed ID: 2514618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease.
    Pironi L; Miglioli M; Ruggeri E; Levorato M; Dallasta MA; Corbelli C; Nibali MG; Barbara L
    Dig Dis Sci; 1990 May; 35(5):582-8. PubMed ID: 1691967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increased intestinal permeability to 51 Cr-EDTA among children with persistent diarrhea].
    Sawamura R; Fernandes MI; Troncon LE; Iazigi N
    Arq Gastroenterol; 1997; 34(1):55-61. PubMed ID: 9458961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease.
    Jenkins RT; Ramage JK; Jones DB; Collins SM; Goodacre RL; Hunt RH
    Clin Invest Med; 1988 Apr; 11(2):151-5. PubMed ID: 3135136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.